.
people
.�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian.
.
november 2, 2017
.
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.